Morgan Stanley’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.8M | Buy |
|
|||||
|
2025
Q1 | $31.1M | Buy |
|
|||||
|
2024
Q4 | $27.9M | Sell |
|
|||||
|
2024
Q3 | $17.4M | Buy |
|
|||||
|
2024
Q2 | $18.7M | Sell |
|
|||||
|
2024
Q1 | $32.8M | Sell |
|
|||||
|
2023
Q4 | $50.7M | Buy |
|
|||||
|
2023
Q3 | $23.3M | Buy |
|
|||||
|
2023
Q2 | $10.6M | Buy |
|
|||||
|
2023
Q1 | $10.5M | Buy |
|
|||||
|
2022
Q4 | $3.26M | Buy |
|
|||||
|
2022
Q3 | $7.96M | Buy |
|
|||||
|
2022
Q2 | $9.83M | Buy |
|
|||||
|
2022
Q1 | $8.5M | Buy |
|
|||||
|
2021
Q4 | $2.68M | Buy |
|
|||||
|
2021
Q3 | $121K | Buy |
|
|||||
|
2021
Q2 | $181K | Buy |
|